Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Valerie Morisset
22 Jul 2024
EVP, R&D and CSO
Sell
30,000
$7.98
$239.40K
Valerie Morisset
22 Jul 2024
EVP, R&D and CSO
Sell
39,005
$8.07
$314.77K
Valerie Morisset
19 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.24
$362.00K
Valerie Morisset
19 Jul 2024
EVP, R&D and CSO
Sell
10,201
$7.09
$72.33K
Valerie Morisset
18 Jul 2024
EVP, R&D and CSO
Sell
38,576
$6.93
$267.33K
Valerie Morisset
17 Jul 2024
EVP, R&D and CSO
Sell
3,207
$6.91
$22.16K
Valerie Morisset
16 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.13
$356.50K
Valerie Morisset
15 Jul 2024
EVP, R&D and CSO
Sell
42,377
$7.01
$297.06K
Valerie Morisset
12 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.07
$353.50K
Valerie Morisset
11 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.11
$355.50K
Valerie Morisset
10 Jul 2024
EVP, R&D and CSO
Sell
50,000
$6.83
$341.50K
Valerie Morisset
9 Jul 2024
EVP, R&D and CSO
Sell
5,931
$6.66
$39.50K
Valerie Morisset
5 Jul 2024
EVP, R&D and CSO
Sell
12,342
$7.06
$87.13K
Valerie Morisset
3 Jul 2024
EVP, R&D and CSO
Sell
50,000
$6.76
$338.00K
Emily Pimblett
20 Jun 2024
Chief Accounting Officer
Sell
1,245
$7.21
$8.98K

What was left out

Form 4 filings counted 96
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,676,580
History held since 11 Aug 2021